• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

政府规制模式下疫苗生产企业决策演化的博弈分析

Game Analysis on the Evolution of Decision-Making of Vaccine Manufacturing Enterprises under the Government Regulation Model.

作者信息

Zhang Na, Yang Yingjie, Wang Xiaodong, Wang Xinfeng

机构信息

School of Economics and Management, Shihezi University, Shihezi 832000, China.

Guanghua School of Management, Peking University, Beijing 100871, China.

出版信息

Vaccines (Basel). 2020 May 31;8(2):267. doi: 10.3390/vaccines8020267.

DOI:10.3390/vaccines8020267
PMID:32486520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7378765/
Abstract

The harm caused by defective vaccines to human health and social stability is immeasurable. Aiming at the government's supervision of the vaccine market, an evolutionary game model is constructed to analyze the quality of supervision and the key factors in the dynamic interaction between government departments and vaccine manufacturers under different supervision modes in the vaccine manufacturing process. The results show that: (1) Severe punishment by government regulatory authorities, and increased costs of rectification after investigation and handling of involuntary behaviors of vaccine enterprises can effectively prevent involuntary behaviors of vaccine enterprises. (2) In the early stage of the game, the success rate of the government's efficient supervision will make the vaccine enterprises continuously self-disciplined; when the vaccine market is relatively stable, the government's supervision departments tend to be more conducive to passive supervision. (3) The success rate of government regulatory departments and the probability of a third-party reporting to play a great role in promoting the self-discipline of enterprises. (4) The power of government and regulation are conducive to promoting the active supervision of the government regulatory authorities but corruption of government and awareness of people are different. Once the phenomenon of vaccine enterprises' non-discipline increases, the government regulation must change from passive regulation to active regulation. Therefore, the government should implement different measures according to the characteristics of each period in the manufacturing process to effectively prevent problematic vaccines. The conclusions and policy recommendations are significant for addressing the issue of insufficient self-discipline of vaccine manufacturers.

摘要

不合格疫苗对人类健康和社会稳定造成的危害不可估量。针对政府对疫苗市场的监管,构建进化博弈模型,分析疫苗生产过程中不同监管模式下政府部门与疫苗生产企业动态互动中的监管质量及关键因素。结果表明:(1)政府监管部门严厉处罚,以及对疫苗企业非自愿行为查处后的整改成本增加,能有效防范疫苗企业的非自愿行为。(2)在博弈初期,政府高效监管的成功率会使疫苗企业不断自律;当疫苗市场相对稳定时,政府监管部门倾向于更有利于被动监管。(3)政府监管部门的成功率和第三方举报概率对促进企业自律作用很大。(4)政府权力和监管有利于促进政府监管部门主动监管,但政府腐败和民众意识不同。一旦疫苗企业不自律现象增多,政府监管必须从被动监管转变为主动监管。因此,政府应根据生产过程各阶段特点实施不同措施,有效防范问题疫苗。研究结论和政策建议对解决疫苗生产企业自律不足问题具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/958715babb0f/vaccines-08-00267-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/8070f5fa54da/vaccines-08-00267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/953644455cfe/vaccines-08-00267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/7df4361e5081/vaccines-08-00267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/88e72d67f7cb/vaccines-08-00267-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/38e58572234a/vaccines-08-00267-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/4d4d20710ab1/vaccines-08-00267-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/b438b026855b/vaccines-08-00267-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/958715babb0f/vaccines-08-00267-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/8070f5fa54da/vaccines-08-00267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/953644455cfe/vaccines-08-00267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/7df4361e5081/vaccines-08-00267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/88e72d67f7cb/vaccines-08-00267-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/38e58572234a/vaccines-08-00267-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/4d4d20710ab1/vaccines-08-00267-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/b438b026855b/vaccines-08-00267-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/098b/7378765/958715babb0f/vaccines-08-00267-g008.jpg

相似文献

1
Game Analysis on the Evolution of Decision-Making of Vaccine Manufacturing Enterprises under the Government Regulation Model.政府规制模式下疫苗生产企业决策演化的博弈分析
Vaccines (Basel). 2020 May 31;8(2):267. doi: 10.3390/vaccines8020267.
2
Evolutionary game analysis of coal enterprise resource integration under government regulation.政府规制下煤炭企业资源整合的演化博弈分析。
Environ Sci Pollut Res Int. 2022 Jan;29(5):7127-7152. doi: 10.1007/s11356-021-15503-z. Epub 2021 Sep 1.
3
Behavioral game and simulation analysis of extended producer responsibility system's implementation under environmental regulations.环境规制下扩展生产者责任制度实施的行为博弈与仿真分析。
Environ Sci Pollut Res Int. 2019 Jun;26(17):17644-17654. doi: 10.1007/s11356-019-05215-w. Epub 2019 Apr 26.
4
Drug Quality Co-regulation Supervision Strategy Considering Collusion Behavior With New Media Participation.考虑新媒体参与的串通行为的药品质量共同监管策略。
Front Public Health. 2022 Apr 29;10:858705. doi: 10.3389/fpubh.2022.858705. eCollection 2022.
5
The tripartite evolutionary game of enterprises' green production strategy with government supervision and people participation.企业绿色生产策略、政府监管与公众参与的三方演化博弈
J Environ Manage. 2024 Nov;370:122627. doi: 10.1016/j.jenvman.2024.122627. Epub 2024 Sep 26.
6
Behavioural strategies of manufacturing firms for high-quality development from the perspective of government participation: A three-part evolutionary game analysis.从政府参与视角看制造企业高质量发展的行为策略:一个三阶段演化博弈分析
Heliyon. 2023 Mar 29;9(4):e14982. doi: 10.1016/j.heliyon.2023.e14982. eCollection 2023 Apr.
7
Developing a Decision-Making Model for Construction Safety Behavior Supervision: An Evolutionary Game Theory- Analysis.构建建筑安全行为监管决策模型:基于进化博弈论的分析
Front Psychol. 2022 Apr 7;13:861828. doi: 10.3389/fpsyg.2022.861828. eCollection 2022.
8
Evolutionary game of environmental investment under national environmental regulation in China.中国国家环境规制下环境投资的演化博弈。
Environ Sci Pollut Res Int. 2021 Oct;28(38):53432-53443. doi: 10.1007/s11356-021-14548-4. Epub 2021 May 24.
9
An Evolutionary Game Theory Study for Construction and Demolition Waste Recycling Considering Green Development Performance under the Chinese Government's Reward-Penalty Mechanism.考虑中国政府奖惩机制下绿色发展绩效的建筑和拆除废物回收的演化博弈理论研究。
Int J Environ Res Public Health. 2020 Aug 29;17(17):6303. doi: 10.3390/ijerph17176303.
10
Evolutionary game analysis on the recycling strategy of household medical device enterprises under government dynamic rewards and punishments.政府动态奖惩下的家用医疗器械企业回收策略的演化博弈分析。
Math Biosci Eng. 2021 Jul 28;18(5):6434-6451. doi: 10.3934/mbe.2021320.

引用本文的文献

1
China's Jinshan Yinshan sustainability evolutionary game equilibrium research under government and enterprises resource constraint dilemma.中国的金山银山可持续发展演化博弈均衡研究——在政府和企业资源约束困境下。
Environ Sci Pollut Res Int. 2022 Jun;29(27):41012-41036. doi: 10.1007/s11356-022-18786-y. Epub 2022 Jan 27.

本文引用的文献

1
Trust collapse caused by the Changsheng vaccine crisis in China.信任崩塌:中国长生疫苗危机
Vaccine. 2019 Jun 6;37(26):3419-3425. doi: 10.1016/j.vaccine.2019.05.020. Epub 2019 May 13.
2
Lessons from the Chinese defective vaccine case.中国问题疫苗事件的教训。
Lancet Infect Dis. 2019 Mar;19(3):245. doi: 10.1016/S1473-3099(19)30062-3.
3
Development of a valid and reliable scale to assess parents' beliefs and attitudes about childhood vaccines and their association with vaccination uptake and delay in Ghana.
开发一种有效的、可靠的量表来评估加纳父母对儿童疫苗的信念和态度及其与疫苗接种率和延迟接种的关系。
Vaccine. 2019 Feb 4;37(6):848-856. doi: 10.1016/j.vaccine.2018.12.055. Epub 2019 Jan 11.
4
Development of a US trust measure to assess and monitor parental confidence in the vaccine system.开发美国信托措施以评估和监测父母对疫苗系统的信心。
Vaccine. 2019 Jan 7;37(2):325-332. doi: 10.1016/j.vaccine.2018.09.043. Epub 2018 Nov 30.
5
Measuring vaccine confidence: introducing a global vaccine confidence index.衡量疫苗信心:引入全球疫苗信心指数。
PLoS Curr. 2015 Feb 25;7:ecurrents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4. doi: 10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4.
6
Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria.疫苗接种后不良事件监测:维多利亚州的SAEFVIC模型
Commun Dis Intell Q Rep. 2011 Dec;35(4):294-8. doi: 10.33321/cdi.2011.35.28.
7
Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.确保许可疫苗的最佳安全性:疫苗研究、开发和制造公司的观点。
Pediatrics. 2011 May;127 Suppl 1:S16-22. doi: 10.1542/peds.2010-1722D. Epub 2011 Apr 18.
8
Evaluating the safety of new vaccines: summary of a workshop.评估新型疫苗的安全性:研讨会总结
Am J Public Health. 2005 May;95(5):800-7. doi: 10.2105/AJPH.2004.039438.
9
United States vaccine research: a delicate fabric of public and private collaboration. National Vaccine Advisory Committee.美国疫苗研究:公共与私人合作的微妙架构。国家疫苗咨询委员会。
Pediatrics. 1997 Dec;100(6):1015-20. doi: 10.1542/peds.100.6.1015.